BioCentury
ARTICLE | Clinical News

Univax regulatory update

December 6, 1993 8:00 AM UTC

Univax Biologics Inc. (UNVX) The FDA granted UNVX's WinRho SD orphan drug designation to treat idiopathic thrombocytopenic purpura. The company filed a PLA for the polyclonal antibody in June. ...